December 2017 FDA Recall Famciclovir by Hetero Labs Limited Unit V
D-0415-2018 - Temperature Abuse

This Class II drug recall was voluntarily initiated by Hetero Labs Limited Unit V on December 22, 2017 for the product Famciclovir. The FDA reported the reason for recall as temperature abuse. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0415-2018

Reason for Recall
Temperature Abuse: Complaints of tablets being wet and stuck together with tablet coating peeled and disintegrated as a result of prolonged exposure to high temp during distribution.
Initiated
12-22-2017
Reported
02-21-2018
Quantity
8,436 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Hetero Labs Limited Unit V
Nationwide in the USA.
Famciclovir Tablets, 500 mg, 30-count bottles, Rx Only, Manufactured For: Camber Pharmaceuticals. Inc. Piscataway, NJ 08854 By: HETERO, Hetero Labs Limited, Unit V, Polepally, Jadcherla, Mahaboob Nagar-509 301, India. NDC 31722-708-30

Batch or Lot Expiration Information

Lot# FMC17039, Exp 07/2019.